{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:55:52Z","timestamp":1786992952165,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jneuroim.2022.578000","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T22:48:59Z","timestamp":1668638939000},"page":"578000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis"],"prefix":"10.1016","volume":"373","author":[{"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Edward","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.578000_bb0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","article-title":"Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.578000_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000000444","article-title":"Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies)","volume":"30","author":"Bastiaansen","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0020","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00259-021-05299-y","article-title":"Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis","volume":"48","author":"Bordonne","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jneuroim.2022.578000_bb0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/RLU.0000000000003469","article-title":"18F-FDG PET\/CT in anti-leucine-rich glioma-inactivated 1 antibody encephalitis: typical pattern and follow-up","volume":"46","author":"Caquot","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2020.10.003","article-title":"Hypernatremia and moderate-to-severe hyponatremia are independent predictors of mortality in septic patients at emergency department presentation: a sub-group analysis of the need-speed trial","volume":"83","author":"Castello","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0035","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMcpc1913477","article-title":"Case 15-2020: a 79-year-old man with hyponatremia and involuntary movements of the arm and face","volume":"382","author":"Cooper","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3389\/fneur.2020.00852","article-title":"Clinical characteristics of cognitive impairment and 1-year outcome in patients with anti-LGI1 antibody encephalitis","volume":"11","author":"Hang","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0055","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA. Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fneur.2020.00418","article-title":"The clinical value of 18F-FDG-PET in autoimmune encephalitis associated with LGI1 antibody","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0080","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1474-4422(16)30140-5","article-title":"Role of 18F-FDG-PET imaging in the diagnosis of autoimmune encephalitis","volume":"15","author":"Morbelli","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0085","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000974","article-title":"Clinical and prognostic value of Immunogenetic characteristics in anti-LGI1 encephalitis","volume":"8","author":"Muniz-Castrillo","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/NDT.S292343","article-title":"Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis: a multi-center study","volume":"17","author":"Qiao","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0105","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1212\/WNL.0000000000012465","article-title":"Clinical course and features of seizures associated with LGI1-antibody encephalitis","volume":"97","author":"Smith","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000652","article-title":"Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis","volume":"7","author":"Sola-Valls","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0115","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.05.048","article-title":"Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy","volume":"343","author":"Szots","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/WNL.0b013e31825f0522","article-title":"Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis","volume":"79","author":"Tofaris","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0130","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3389\/fimmu.2017.01364","article-title":"Selective limbic blood-brain barrier breakdown in a feline model of limbic encephalitis with LGI1 antibodies","volume":"8","author":"Tr\u00f6scher","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.578000_bb0135","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000633","article-title":"Anti-NMDAR encephalitis: a single-center, longitudinal study in China","volume":"7","author":"Xu","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:43:20Z","timestamp":1759049000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"alternative-id":["S0165572822001953"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.578000","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.578000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578000"}}